SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Jan-24 5:04 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 09-Jan-24 | Market Sale | 2,812 | $16.33 | $45,914.60 | (1%) 208.42K to 205.6K | (2%) |
17-May-23 4:58 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 15-May-23 | Option Exercise | 11,965 | $5.68 | $67,990.70 | 6% 208.42K to 220.38K | |
17-May-23 4:58 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 15-May-23 | Planned Option Sale | 11,965 | $29.03 | $347,358.00 | (5%) 220.38K to 208.42K | |
19-Apr-23 7:45 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 17-Apr-23 | Option Exercise | 49,579 | $0.99 | $49,058.40 | 24% 208.42K to 258.0K | |
19-Apr-23 7:45 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 17-Apr-23 | Planned Option Sale | 49,579 | $30.54 | $1,513,940.00 | (19%) 258.0K to 208.42K | |
20-Mar-23 8:25 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Grant | 9,167 | -- | -- | 4% 204.3K to 213.47K | |
20-Mar-23 8:25 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Sale (Planned) | 54,627 | $31.87 | $1,741,200.00 | (26%) 213.47K to 158.84K | |
10-Jan-23 7:22 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-23 | Sale (Planned) | 2,034 | $36.30 | $73,831.00 | 1% 202.26K to 204.3K | |
10-Jan-22 8:34 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-22 | Grant | 28,333 | -- | -- | 16% 178.0K to 206.33K |